LXRs function in cholesterol metabolism was first described in 1998, when it was shown that mice lacking LXRα develop NASH when fed a 2% cholesterol diet due to impaired hepatocyte cholesterol excretion (84). Here, NR1H3 is linked to metabolic dysfunction-associated steatohepatitis.